Article

Gene Editing: The Regulatory Perspective

2023-07-31

Abstract excerpt

Gene or genome editing (GE) revises, removes, or replaces a mutated gene at the DNA level; it is a tool. Gene therapy (GT) offsets mutations by introducing a "normal" version of the gene into the body while the diseased gene remains in the genome; it is a medicine. So far, no GE product has been approved, as opposed to 22 GT products that cost up to millions of dollars per dose. The FDA has recently adde...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9ba060db-31dd-56f5-a165-bcdd6cad801c
DOI: 10.20944/preprints202307.2062.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Gene Editing: The Regulatory PerspectiveDOI 10.20944/preprints202307.2062.v1Read

In Vivo Gene Editing: A Healthcare Revolution in the MakingSemantic proximity Read

Gene editing and its applications in biomedicineSemantic proximity Read

Gene editing: not just for translation anymore.Semantic proximity Read

The Clinical Application of Gene Editing: Ethical and Social IssuesSemantic proximity Read

A New Class of Medicines through DNA EditingSemantic proximity Read

Human germline gene editing: Recommendations of ESHG and ESHRESemantic proximity Read

Gene and cell therapy of human genetic diseases: Recent advances and future directionsSemantic proximity Read

Genome Editing – An Ethical ReviewSemantic proximity Read

The history, use, and challenges of therapeutic somatic cell and germline gene editing.Semantic proximity Read

Revising, Correcting, and Transferring GenesSemantic proximity Read

Ethics of Human Genome EditingSemantic proximity Read

Edição genética e terapias gênicas: aplicações clínicas, desafios e perspectivas para a biomedicinaSemantic proximity Read